Qunsheng Ji Selected Research

Qunsheng Ji Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 02/2011
6	Stomach Neoplasms (Stomach Cancer) 01/2017 - 08/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2015 - 12/2012
2	Hepatocellular Carcinoma (Hepatoma) 12/2017 - 08/2015
2	Carcinogenesis 06/2015 - 04/2015
2	Carcinoma (Carcinomatosis) 03/2014 - 08/2012
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 10/2014
1	Malignant Pleural Effusion 12/2013
1	Lung Neoplasms (Lung Cancer) 12/2012
1	Esophageal Squamous Cell Carcinoma 08/2012
1	Breast Neoplasms (Breast Cancer) 04/2012

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 08/2017 - 03/2015
3	Trastuzumab (Herceptin)FDA Link 04/2015 - 04/2012
3	Docetaxel (Taxotere)FDA Link 03/2015 - 04/2012
3	Proteins (Proteins, Gene)FDA Link 10/2014 - 08/2012
3	Small Interfering RNA (siRNA)IBA 05/2014 - 05/2013
2	Phosphotransferases (Kinase)IBA 06/2015 - 10/2013
2	capivasertibIBA 10/2013 - 04/2012
2	AZD4547IBA 05/2013 - 12/2012
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2013 - 12/2012
1	Immune Checkpoint InhibitorsIBA 01/2022
1	LipidsIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	LigandsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	CytokinesIBA 11/2018
1	Sorafenib (BAY 43-9006)FDA Link 12/2017
1	regorafenibIBA 12/2017
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 08/2017
1	Biomarkers (Surrogate Marker)IBA 06/2015
1	vandetanib (ZD6474)IBA 03/2015
1	Pemetrexed (MTA)FDA Link 03/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2015
1	AZD 6244IBA 11/2014
1	Messenger RNA (mRNA)IBA 11/2014
1	IsoenzymesIBA 05/2014
1	PKC-3 proteinIBA 05/2014
1	cathepsin SIBA 03/2014
1	ErbB Receptors (EGF Receptor)IBA 12/2013
1	tyrosine receptor (receptor, tyrosine)IBA 10/2013
1	Gefitinib (Iressa)FDA Link 07/2013
1	Adenosine Triphosphate (ATP)IBA 05/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2012
1	Lapatinib (GW572016)FDA Link 04/2012
1	Insulin-Like PeptidesIBA 02/2011

Therapy/Procedure

5	Therapeutics 01/2022 - 07/2013
2	Drug Therapy (Chemotherapy) 01/2017 - 10/2014
1	Immunotherapy 01/2022
1	Precision Medicine 04/2012